These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 124475

  • 1. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL, Katz AJ, Feinstein MB.
    Thromb Diath Haemorrh; 1975 Apr 30; 33(2):286-309. PubMed ID: 124475
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
    Thromb Haemost; 1997 Apr 30; 77(4):741-7. PubMed ID: 9134653
    [Abstract] [Full Text] [Related]

  • 3. Platelet interaction with polymerizing fibrin.
    Niewiarowski S, Regoeczi E, Stewart GJ, Senyl AF, Mustard JF.
    J Clin Invest; 1972 Mar 30; 51(3):685-99. PubMed ID: 4622107
    [Abstract] [Full Text] [Related]

  • 4. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
    Phillips DR.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):207-15. PubMed ID: 4454040
    [Abstract] [Full Text] [Related]

  • 5. Effects of plasmin on rabbit platelets.
    Guccione MA, Kinlough-Rathbone RL, Packham MA, Harfenist EJ, Rand ML, Greenberg JP, Perry DW, Mustard JF.
    Thromb Haemost; 1985 Feb 18; 53(1):8-14. PubMed ID: 3158094
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF.
    Thromb Haemost; 1976 Feb 29; 35(1):151-66. PubMed ID: 785686
    [Abstract] [Full Text] [Related]

  • 7. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC, Tullis JL, Kenney DM, Conneely GS, Doyle JR.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):216-31. PubMed ID: 4454041
    [Abstract] [Full Text] [Related]

  • 8. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD, Kinlough-Rathbone RL, Mustard JF.
    J Lab Clin Med; 1986 Feb 30; 107(2):148-53. PubMed ID: 3080538
    [Abstract] [Full Text] [Related]

  • 9. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.
    Niewiarowski S, Senyi AF, Gillies P.
    J Clin Invest; 1973 Jul 30; 52(7):1647-59. PubMed ID: 4268896
    [Abstract] [Full Text] [Related]

  • 10. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M, Watanabe T, Koike K, Sakuragawa N.
    Rinsho Ketsueki; 1974 May 30; 15(5):519-23. PubMed ID: 4277899
    [No Abstract] [Full Text] [Related]

  • 11. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL, Packham MA, Mustard JF.
    Thromb Haemost; 1984 Aug 31; 52(1):75-80. PubMed ID: 6495268
    [Abstract] [Full Text] [Related]

  • 12. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 13. Characterization of plasmin-induced platelet aggregation.
    Watabe A, Ohta M, Matsuyama N, Mizuno K, el Borai N, Tanimoto T, Kawanishi T, Hayakawa T.
    Res Commun Mol Pathol Pharmacol; 1997 Jun 19; 96(3):341-52. PubMed ID: 9261893
    [Abstract] [Full Text] [Related]

  • 14. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL, Packham MA.
    Thromb Haemost; 1992 Aug 03; 68(2):189-93. PubMed ID: 1412166
    [Abstract] [Full Text] [Related]

  • 15. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
    Rabhi-Sabile S, Pidard D.
    Thromb Haemost; 1995 Apr 03; 73(4):693-701. PubMed ID: 7495081
    [Abstract] [Full Text] [Related]

  • 16. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A, Robson CA.
    J Pharmacol Exp Ther; 1997 May 03; 281(2):861-7. PubMed ID: 9152395
    [Abstract] [Full Text] [Related]

  • 17. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD, Kinlough-Rathbone RL, Mustard JF.
    Thromb Haemost; 1981 Jun 30; 45(3):257-62. PubMed ID: 7281105
    [Abstract] [Full Text] [Related]

  • 18. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
    Cattaneo M, Akkawat B, Kinlough-Rathbone RL, Packham MA, Cimminiello C, Mannucci PM.
    Thromb Haemost; 1994 Jan 30; 71(1):91-4. PubMed ID: 8165651
    [Abstract] [Full Text] [Related]

  • 19. Ultrastructural studies on the binding sites of fibrinogen on platelet surface during aggregation.
    Morgenstern E, Reimers HJ, Miyashita C.
    Acta Histochem Suppl; 1984 Jan 30; 29():183-9. PubMed ID: 6232644
    [Abstract] [Full Text] [Related]

  • 20. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH, Senzel L, Bielawska A, Khan W, Hannun YA.
    Mol Pharmacol; 1991 Apr 30; 39(4):547-56. PubMed ID: 2017154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.